BECOTATUG VEDOTIN

Clinical trials for BECOTATUG VEDOTIN explained in plain language.

Never miss a new study

Get alerted when new BECOTATUG VEDOTIN trials appear

Sign up with your email to follow new studies for BECOTATUG VEDOTIN, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1

New triple therapy hopes to outsmart tough esophageal cancer

Disease control Not yet recruiting

This study tests a new combination of three drugs—becotatug vedotin, tislelizumab, and chemotherapy—for people with advanced esophageal squamous cell carcinoma (ESCC) who have not had prior treatment. The goal is to see if adding the targeted drug becotatug vedotin to standard im…

Matched conditions: BECOTATUG VEDOTIN

Phase: PHASE2 • Sponsor: Tianjin Medical University Cancer Institute and Hospital • Aim: Disease control

Last updated Jun 15, 2026 18:57 UTC

BECOTATUG VEDOTIN

Get alerted when new BECOTATUG VEDOTIN trials appear

New triple therapy hopes to outsmart tough esophageal cancer